Invention Grant
- Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban
-
Application No.: US16391444Application Date: 2019-04-23
-
Publication No.: US10583126B2Publication Date: 2020-03-10
- Inventor: Leo Pavliv , Bryan Voss , James West , Erica Carrier
- Applicant: Cumberland Pharmaceuticals Inc. , Vanderbilt University
- Applicant Address: US TN Nashville US TN Nashville
- Assignee: CUMBERLAND PHARMACEUTICALS INC.,Vanderbilt University
- Current Assignee: CUMBERLAND PHARMACEUTICALS INC.,Vanderbilt University
- Current Assignee Address: US TN Nashville US TN Nashville
- Agency: Vivicar Law, PLLC
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/20 ; A61K9/48 ; A61K31/421 ; A61K31/422 ; C07D263/30 ; C07D407/04 ; C07D413/04 ; C07D493/08
Abstract:
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190247364A1 Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban Public/Granted day:2019-08-15
Information query
